Cargando…

The Impact of COVID-19 in Cystic Fibrosis

Detalles Bibliográficos
Autores principales:	Flume, Patrick A., Saiman, Lisa, Marshall, Bruce
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SEPAR. Published by Elsevier España, S.L.U. 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8679495/ https://www.ncbi.nlm.nih.gov/pubmed/34934258 http://dx.doi.org/10.1016/j.arbres.2021.12.003

Ejemplares similares

State of progress in treating cystic fibrosis respiratory disease
por: Flume, Patrick A, et al.
Publicado: (2012)

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
por: Floto, R Andres, et al.
Publicado: (2016)

Impact of the COVID-19 pandemic: How our response is shaping the future of cystic fibrosis care()
por: Sabadosa, Kathryn A., et al.
Publicado: (2021)

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary
por: Floto, R Andres, et al.
Publicado: (2016)

In Vitro Activity of Ceftolozane/Tazobactam vs Nonfermenting, Gram-Negative Cystic Fibrosis Isolates
por: Forrester, Jeanne B, et al.
Publicado: (2018)

Is cystic fibrosis a risk factor for COVID-19 infection or related complications?
por: Athanazio, Rodrigo A
Publicado: (2022)

Developing Inhaled Antibiotics in Cystic Fibrosis: Current Challenges and Opportunities
por: Nichols, Dave P., et al.
Publicado: (2019)

Cystic fibrosis revisited
por: Kulkarni, H, et al.
Publicado: (2019)

Early Antibiotics in Cystic Fibrosis: Lessons from the Cystic Fibrosis Pig Model
por: Lu, Shiping, et al.
Publicado: (2021)

Cystic Fibrosis Screen Positive, Inconclusive Diagnosis Genotypes in the Cystic Fibrosis Registry
por: Thompson, Cassandra, et al.
Publicado: (2023)

Pseudomonas aeruginosa Susceptibility Patterns and Associated Clinical Outcomes in People with Cystic Fibrosis following Approval of Aztreonam Lysine for Inhalation
por: Keating, Claire L., et al.
Publicado: (2021)

Abdominal Surgical Procedures in Adult Patients With Cystic Fibrosis: What Are the Risks?
por: Hite, Melissa A., et al.
Publicado: (2022)

Impact of COVID-19 on people with cystic fibrosis
por: Colombo, Carla, et al.
Publicado: (2020)

Impact of the SARS-CoV-2 pandemic on cystic fibrosis centres and care: survey results from US centres
por: Muhlebach, Marianne S., et al.
Publicado: (2021)

Clinical Advances in Cystic Fibrosis
por: Imperlini, Esther, et al.
Publicado: (2022)

Cystic Fibrosis: “Ionocyte Modulators”?
por: Shah, Viral S., et al.
Publicado: (2023)

When is cystic fibrosis not cystic fibrosis? The importance of appropriately classifying patients
por: Faro, Albert, et al.
Publicado: (2022)

The treatment burden of cystic fibrosis: a day-to-day experience with treatment as someone with cystic fibrosis
por: Maetz, Jessica, et al.
Publicado: (2021)

Optimising inhaled mannitol for cystic fibrosis in an adult population
por: Flume, Patrick A., et al.
Publicado: (2015)

Prerenal azotemia from excessive sweating in an adult with a cystic fibrosis gene mutation
por: Tomov, S. V., et al.
Publicado: (2011)

Mitigating the Impact of Socioeconomic Status on Listing for Lung Transplantation in Cystic Fibrosis
por: Hadjiliadis, Denis
Publicado: (2020)

A New Era for Cystic Fibrosis and Cystic Fibrosis Transmembrane Conductance Regulator Modulator Trials in Infants
por: Wainwright, Claire E.
Publicado: (2022)

Cystic fibrosis in Brazil: achievements in survival
por: Vendrusculo, Fernanda Maria, et al.
Publicado: (2021)

Evidence for Early Cystic Fibrosis Transmembrane Conductance Regulator Modulator Treatment for Children with Cystic Fibrosis Keeps Growing
por: Hoppe, Jordana E., et al.
Publicado: (2022)

CFTR modulators: transformative therapies for cystic fibrosis
por: Dwight, Mary, et al.
Publicado: (2021)

Improved Prognosis in Cystic Fibrosis: Consideration for Intensive Care during the COVID-19 Pandemic
por: Ramos, Kathleen J., et al.
Publicado: (2020)

Age at Lung Transplant Impacts Post-Transplant Survival in Cystic Fibrosis; Why?
por: Clausen, Emily S., et al.
Publicado: (2021)

New Developments in Cystic Fibrosis Airway Inflammation
por: Palaniyar, Nades, et al.
Publicado: (2015)

Falling through the Cracks—The Impact of Care Gaps on Lung Function Loss in Cystic Fibrosis
por: Love, Allison J., et al.
Publicado: (2023)

Dornase alpha use in patients with cystic fibrosis
por: Marostica, Paulo José C.
Publicado: (2013)

Ciprofloxacin dry powder inhaler in cystic fibrosis
por: Elborn, J Stuart
Publicado: (2016)

Comparing cystic fibrosis outcomes across the pond
por: Taylor-Robinson, David C, et al.
Publicado: (2015)

Steps toward Cell Therapy for Cystic Fibrosis
por: Koh, Kyung Duk, et al.
Publicado: (2020)

Cystic fibrosis-related diabetes: The unmet need
por: Pozo, Leonardo, et al.
Publicado: (2020)

Preclinical Modeling for Therapeutic Development in Cystic Fibrosis
por: Bonfield, Tracey L.
Publicado: (2020)

Cystic Fibrosis Inflammation: Hyperinflammatory, Hypoinflammatory, or Both?
por: Murphy, Sean V., et al.
Publicado: (2019)

Where Is the Cystic Fibrosis Transmembrane Conductance Regulator?
por: Barbry, Pascal, et al.
Publicado: (2021)

Improvements in anthropometric measures and gastrointestinal tolerance in patients with cystic fibrosis by using a digestive enzyme cartridge with overnight enteral nutrition
por: Hendrix, Sara J., et al.
Publicado: (2022)

International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety
por: Quittner, Alexandra L, et al.
Publicado: (2016)

COVID-19 vaccine prioritisation for people with cystic fibrosis
por: Carr, Siobhán B, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dc7u204rsfgqg9cqgaougt24aq